The Child Development Inventory: A developmental outcome measure for follow-up of the high-risk infant

K B Doig1, M M Macias, C F Saylor

  • 1Division of Genetics and Child Development, Department of Pediatrics, Medical University of South Carolina, Charleston 29425, USA.

The Journal of Pediatrics
|September 15, 1999
PubMed

Insights

The Child Development Inventory (CDI) accurately screens high-risk infants for developmental outcomes, correlating well with established measures. It offers a cost-effective and reliable tool for early detection.

Area of Science:

  • Pediatric developmental assessment
  • Neonatal follow-up care
  • Screening tool validation

Background:

  • High-risk infants require accurate developmental monitoring.
  • Existing developmental outcome measures have limitations.
  • The Child Development Inventory (CDI) is a potential screening tool.

Purpose of the Study:

  • To validate the Child Development Inventory (CDI) against established developmental outcome measures in high-risk infants.
  • To assess the CDI's effectiveness in identifying developmental outcomes.
  • To determine the CDI's utility in routine neonatal high-risk follow-up clinics.

Main Methods:

  • Caregivers of 43 toddlers and preschoolers in a neonatal high-risk clinic completed the CDI.
  • The CDI General Development Developmental Quotient was compared with the Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS) and the Bayley Scales of Infant Development, 2nd Edition (BSID-II).

Main Results:

  • The CDI showed significant correlations with both the CAT/CLAMS (r=.87) and the BSID-II (r=.86).
  • The CDI demonstrated high sensitivity (80-100%) and specificity (94-96%).
  • No significant correlations were found between the CDI and parent education or income.

Conclusions:

  • The Child Development Inventory (CDI) is a valid and reliable screening measure for developmental outcomes in high-risk infants.
  • The CDI is a cost-effective tool for early detection of developmental issues.
  • The CDI can be effectively utilized in neonatal high-risk follow-up settings.
Abstract